Merck's bowel disease drug meets main goal in late-stage trial
22/06/2026 12:13
Merck's bowel disease drug meets main goal in late-stage trial June 22 (Reuters) - Merck MRK.N said on Monday its drug met the main goal in a late-stage trial testing it in patients with a type of inflammatory bowel disease.
(Reporting by Christy Santhosh in Bengaluru; Editing by Leroy Leo)
Recent news on Merck & Co
See all newsU.S. STOCKS ON THE MOVE-Chip stocks, Unicycive, Roblox
U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin
Eli Lilly, Pfizer slip after US House panel probing China clinical trials
US House committee opens investigation into Merck, AbbVie China drug trials (updated)
Brief: U.S. House Committee Sends Letters To Pfizer, Eli Lilly & Bristol Myers Squibb Probing China Drug Trials